Viewing Study NCT06714708


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-26 @ 10:57 AM
Study NCT ID: NCT06714708
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2024-11-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
Sponsor: Anhui Provincial Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module